Clinical Trial Update: RejuvenAir Lobectomy for Safety and Histology [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates for RejuvenAir Lobectomy focusing on safety and histology in lung neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: CSA Medical, Inc. | Conditions: Lung Neoplasms, Pulmonary Neoplasms | Phase 1, Phase 2 | Status: COMPLETED